OXTR and Arrhythmia: Importantly, the incidence of arrhythmias was lower in the MI rats that received an oxytocin receptor antagonist either centrally (atosiban, 4.5 μg in 5 μl, i.c.v.)or intravenously (retosiban, 3 mg/kg) (Fig. 6b).